Glucagon (rDNA origin, Lilly)

胰高血糖素（礼来）

Report date: 2026/05/21 20:00:22

Base Information

Drug NameGlucagon (rDNA origin, Lilly)
Drug Alias NameGlucagonum (rDNA origin, Lilly)升糖素（礼来）胰高糖素（礼来）升血糖激素（礼来）高血糖素（礼来） +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionGlucagon receptor agonists
TargetsGlucagon receptor
Therapy Area/IndicationsObesityHypoglycemiaInsulin Resistance +[4] 
Global Approved IndicationsHypoglycemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1998/09/11
Country/TerritoryCanadaUnited StatesAustria
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesUT Health San Antonio
Inactive CompaniesEli Lilly And CompanyXeris Pharmaceuticals IncUniversity Health Network (Uhn)
Active IndicationsInsulin Resistance
Inactive IndicationsObesityHypoglycemiaDiabetes Mellitus, Type 1

Other Information

ATC CodeH04AA01
Related LinksKEGG